OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
Gregg W. Stone, Michael E. Farkouh, Anuradha Lala, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 18, pp. 1747-1762
Open Access | Times Cited: 49

Showing 26-50 of 49 citing articles:

Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial
Antonio Landi, Nuccia Morici, Pascal Vranckx, et al.
Journal of Cardiovascular Medicine (2023) Vol. 24, Iss. 12, pp. 920-930
Closed Access | Times Cited: 2

VTE prevention in medical inpatients - Current approach and controversies
Rachel E. Clapham, Elizabeth Marrinan, Lara N. Roberts
Thrombosis Update (2023) Vol. 13, pp. 100151-100151
Open Access | Times Cited: 2

Ultrastructural characterization of alveolar microvascular damage in severe COVID-19 respiratory failure
Elnara Márcia Negri, Marlene Benchimol, Thaís Mauad, et al.
Journal of Applied Physiology (2023) Vol. 135, Iss. 4, pp. 950-955
Closed Access | Times Cited: 2

Therapeutic-Dose Anticoagulation in Hospitalized Patients With COVID-19
David D. Berg
JACC Advances (2024) Vol. 3, Iss. 3, pp. 100779-100779
Open Access

COVID-19 and Pulmonary Hypertension: An Interesting Dynamic
Saam Foroshani, Michael Airo, Avi Levine, et al.
Cardiology in Review (2024)
Closed Access

Editor-in-Chief’s Top Picks From 2023
Valentı́n Fuster
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 10, pp. 961-1026
Closed Access

How COVID-19 Can Damage the Heart? – Association of Cardiac Injury with COVID-19: A Narrative Review
Catarina Gregório, Daniel Caldeira, Dulce Brito, et al.
Heart and Mind (2024)
Open Access

Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial
Pedro Gabriel Melo de Barros e Silva, Remo H.M. Furtado, Mariana Silveira de Alcântara Chaud, et al.
Journal of Thrombosis and Thrombolysis (2024) Vol. 57, Iss. 6, pp. 1031-1039
Closed Access

HEART FAILURE AND CHRONIC KIDNEY DISEASE: PROGNOSIS AND THERAPEUTIC AND SURGICAL OPTIONS.
Thelma da Costa, Euripedes da Costa Machado, Layla Azevedo Alencastro Cupertino de Barros, et al.
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 8, pp. 1119-1132
Open Access

Thromboses vasculaires et Covid-19
Jean-Jacques Monsuez
EMC - Angéiologie (2024) Vol. 28, Iss. 1, pp. 1-12
Closed Access

Closer to FREEDOM From Uncertainty
Muthiah Vaduganathan, Behnood Bikdeli
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 18, pp. 1763-1765
Open Access | Times Cited: 1

Outcomes of Hospitalized COVID-19 Patients
Ori Wand, Keren Cohen‐Hagai
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 7, pp. e55-e55
Closed Access | Times Cited: 1

COVID-19-related subclinical myocarditis resulting in mural left ventricular thrombus
Usman Sagheer, Matthew K. shotwell, Muhammad Umer, et al.
QJM (2023) Vol. 116, Iss. 12, pp. 1016-1017
Open Access | Times Cited: 1

Effect of Heparin and Tocilizumab in Patients with Severe COVID-19: The HEPMAB Randomized Clinical Trial
Lucas Trindade Cantú Ribeiro, Lucas Trindade Cantú Ribeiro, Giovanni Landoni, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Reply
Gregg W. Stone, Michael E. Farkouh, Valentı́n Fuster
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 7, pp. e59-e60
Closed Access

Challenges Before Considering Full-Dose Anticoagulation in Noncritically Ill Patients With COVID-19
Mehmet Ağırbaşlı
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 7, pp. e57-e57
Closed Access

Management and Prevention of Venous Thromboembolism in Patients with COVID-19
Olivia Cote, Shaunak Varma, Alexander A. Vakili, et al.
Current Treatment Options in Cardiovascular Medicine (2023) Vol. 25, Iss. 10, pp. 515-524
Closed Access

Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: A propensity score-matched cohort study.
Mateusz Sokolski, Konrad Reszka, Barbara Adamik, et al.
Research Square (Research Square) (2023)
Open Access

Choice and Duration of Anticoagulation for Venous Thromboembolism
Geoffrey D. Barnes, Aroosa Malik, Nghi B. Ha
(2023)
Open Access

COVID-19 und VTE-Prophylaxe
Florian Länger
Springer Reference Medizin (2023), pp. 1-11
Closed Access

Previous Page - Page 2

Scroll to top